NEO is proud to announce that FTSE Russell, the global index, data, and analytics provider, now recognizes the NEO Exchange as an eligible stock exchange for inclusion in FTSE Global Equity indexes.
“Tier 1 stock exchanges remain the only exchanges to be included in indexes around the world – yet not every exchange is recognized and eligible for inclusion,” noted Jos Schmitt, President, and CEO of NEO. “Today marks a pivotal achievement in NEO’s journey to provide much-needed competition and innovation in the Canadian capital markets landscape. Achieving recognition by FTSE Russell is a validation of NEO as a proven and reputable Canadian mainboard stock exchange. This accreditation enables NEO to offer yet another benefit to capital-raising companies, above and beyond our exceptional client service and support, unique liquidity solutions, and unfettered access to market data.”
MindMed (NEO: MMED), (OTCQB: MMEDF), (DE: MMQ), a leading psychedelic medicine biotech company announced that effective as of Friday March 19th, 2021, MindMed has been added to the FTSE Global Micro-Cap Index (which represents $1.3 trillion in global market cap) and the FTSE Total-Cap index (which represents $54.7 trillion in global market cap).
J.R. Rahn, Chief Executive Officer of MindMed said, “Being included in mature and credible indexes like the FTSE Total Cap and FTSE Global Micro-Cap is a true honor. As we build MindMed into a pioneering company for the long-term, our entire team looks forward to the potential positive change we can bring to treating mental health and addiction in the years ahead.”